Concepedia

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

Steven A. Narod, Jean-Sébastien Brunet, Parviz Ghadirian, Mark E. Robson, Ketil Heimdal, Susan L. Neuhausen, Dominique Stoppa-Lyonnet, Caryn Lerman, Barbara Pasini, Patricia de los Rios,

The Lancet · 2000 · 543 citations · 33 references

DOI

Concepts

References

33

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 1998 · 5.5K citations · Full text

, , +15

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

, , +9

Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

Deborah Ford, Douglas F. Easton, Michael R. Stratton et al. · The American Journal of Human Genetics · 1998 · 3K citations · Full text

, , +17

The Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews

Jeffery P. Struewing, Patricia Hartge, Sholom Wacholder et al. · New England Journal of Medicine · 1997 · 2.3K citations · Full text

, , +17

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Steven R. Cummings, Stephen Eckert, D Grady et al. · JAMA · 1999 · 1.9K citations

, , +16